| IMP3-saRNA Vaccine in Advanced NSCLC (NCT07561723) | West China Hospital | 2026-04-30 |
| Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia (NCT07530666) | Dartsbio Pharmaceuticals Ltd. | 2026-04-30 |
| BR101 in Patients With Relapsed/Refractory Multiple Myeloma (NCT07537049) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-04-30 |
| Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma (NCT07522411) | BinYong Liang | 2026-04-30 |
| JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR (NCT07510841) | Biotech Pharmaceutical Co., Ltd. | 2026-04-30 |
| Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma (NCT07502768) | Rong Tao | 2026-04-30 |
| Mass Balance Study of [14C] LPM3770164 in Healthy Participants (NCT07516899) | Luye Pharma Group Ltd. | 2026-04-30 |
| Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined. (NCT07546942) | Black Tie Medical, Inc. | 2026-04-30 |
| A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult Participants (NCT07535970) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-04-30 |
| A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (NCT07338487) | Second Xiangya Hospital of Central South University | 2026-04-30 |
| A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F) (NCT07286149) | Merck Sharp & Dohme LLC | 2026-04-30 |
| A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor (NCT07566247) | Akeso | 2026-04-30 |
| A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy. (NCT07593027) | ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. | 2026-04-30 |
| Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy (NCT07456852) | Mayo Clinic | 2026-04-30 |
| A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis (NCT07549984) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-04-30 |
| [¹⁴C] Hydronidone Mass Balance Study (NCT07471217) | Beijing Continent Pharmaceutical Co, Ltd. | 2026-04-30 |
| Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX319 Compared With EU-Phesgo® (NCT07495930) | Shanghai Henlius Biotech | 2026-04-30 |
| A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer (NCT07468396) | Gan & Lee Pharmaceuticals. | 2026-04-30 |
| Evaluating the Pharmacokinetics and Safety of Miricorilant (NCT07553663) | Corcept Therapeutics | 2026-04-30 |
| A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults. (NCT07567781) | AbbVie | 2026-04-30 |
| Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease (NCT07570836) | Shanghai Zhongshan Hospital | 2026-04-30 |
| Study to Determine the Comparative Pharmacodynamics of Enoxaparin Sodium Biosimilar With That From Clexane (NCT07517289) | Egyptian International Pharmaceutical Industries Co | 2026-04-30 |
| A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. (NCT07593820) | Vall d'Hebron Institute of Oncology | 2026-04-29 |
| A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease (NCT07377565) | Nielsen Fernandez-Becker | 2026-04-29 |
| Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function (NCT07551557) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-04-29 |
| A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics (NCT07371429) | GlaxoSmithKline | 2026-04-29 |
| Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation (NCT07025538) | City of Hope Medical Center | 2026-04-29 |
| Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer (NCT07575191) | Smartwise Sweden AB | 2026-04-29 |
| A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018) (NCT07530289) | Merck Sharp & Dohme LLC | 2026-04-29 |
| A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms (NCT07469891) | Prelude Therapeutics | 2026-04-29 |
| A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis (NCT07660614) | Leal Therapeutics, Inc | 2026-04-29 |
| A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer (NCT07567846) | Genentech, Inc. | 2026-04-29 |
| A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants (NCT07454291) | Endeavor Biomedicines, Inc. | 2026-04-28 |
| Safety and Tolerability of NCP-IL-22BP mRNA in Advanced Solid Tumors (NCT07562815) | West China Hospital | 2026-04-28 |
| A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants (NCT07528053) | Shanghai Argo Biopharmaceutical Co., Ltd. | 2026-04-28 |
| Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia (NCT07311746) | M.D. Anderson Cancer Center | 2026-04-28 |
| Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy (NCT07562841) | West China Hospital | 2026-04-28 |
| To Test a New Drug (LCFA-01) for Safety and PK in Healthy Adults for Bacterial Vaginosis Infection. (NCT07514416) | Massachusetts General Hospital | 2026-04-28 |
| Safety and Tolerability of AI-Designed Pan-Cancer Neoantigen mRNA Vaccine (PAN-NeoVax) in Advanced Solid Tumors (NCT07560943) | West China Hospital | 2026-04-28 |
| Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL) (NCT07513233) | Capital Medical University | 2026-04-28 |
| Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer (NCT07493512) | Amgen | 2026-04-28 |
| A Phase 1 Study of Navlimetostat Tablet Formulations (NCT07544628) | Bristol-Myers Squibb | 2026-04-27 |
| A Phase 1 Study of BLKR201 in Healthy Adult Participants (NCT07501039) | Formation Bio, Inc. | 2026-04-27 |
| A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (NCT07428486) | M.D. Anderson Cancer Center | 2026-04-27 |
| Phase I Study of HXN6005 in Adult Healthy Participants (NCT07449741) | Helixon Biotechnology (Suzhou) Co., Ltd | 2026-04-27 |
| Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (NCT07225985) | Fred Hutchinson Cancer Center | 2026-04-27 |
| Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer (NCT07328490) | National Cancer Institute (NCI) | 2026-04-25 |
| RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) (NCT07492316) | University of Florida | 2026-04-24 |
| A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENT®(Dupilumab) in Healthy Chinese Volunteers (NCT07502534) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-04-24 |
| First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion (NCT07332858) | Gang Hou | 2026-04-24 |
| ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis (NCT07404033) | Sinomune Pharmaceutical Co., Ltd | 2026-04-24 |
| Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma (NCT07217028) | Vanderbilt-Ingram Cancer Center | 2026-04-24 |
| Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment (NCT07422610) | Novartis Pharmaceuticals | 2026-04-24 |
| PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD) (NCT07429240) | Precision BioSciences, Inc. | 2026-04-24 |
| Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants (NCT07250633) | Institut de Recherches Internationales Servier (I.R.I.S.) | 2026-04-23 |
| Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation (NCT07076498) | M.D. Anderson Cancer Center | 2026-04-23 |
| Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection (NCT07610772) | Aarhus University Hospital | 2026-04-23 |
| Study of Midomafetamine in Healthy Adults (NCT07584720) | Resilient Pharmaceuticals | 2026-04-23 |
| A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy (NCT07580703) | Eli Radiopharma | 2026-04-23 |
| A Food Effect Study of VC005 Tablets in Healthy Adult Subjects. (NCT07533851) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-04-23 |
| Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma (NCT07538206) | Tang-Du Hospital | 2026-04-23 |
| Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy (NCT07545967) | West China Hospital | 2026-04-23 |
| Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies (NCT07504263) | Recurv Pharma Inc | 2026-04-23 |
| SKB103 for Injection in Advanced Solid Tumors (NCT07459998) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-04-23 |
| First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma (NCT07560865) | Masonic Cancer Center, University of Minnesota | 2026-04-23 |
| A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors (NCT07612189) | NEOK Bio, Inc. | 2026-04-22 |
| Phase 1 Study of HS-20152 in Healthy Participants (NCT07503015) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-04-22 |
| A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated (NCT07526194) | Boehringer Ingelheim | 2026-04-22 |
| A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults (NCT07542886) | Pfizer | 2026-04-22 |
| A Study in Healthy People to Test How Vicadrostat Affects the Heart (NCT07513207) | Boehringer Ingelheim | 2026-04-22 |
| Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer (NCT07558733) | Faeth Therapeutics | 2026-04-22 |
| Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer (NCT07371104) | Daewoong Pharmaceutical Co. LTD. | 2026-04-22 |
| Study of Aritinercept in Patients With Generalized Myasthenia Gravis (NCT07596901) | Aurinia Pharmaceuticals Inc. | 2026-04-22 |
| Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation (NCT07548983) | OHSU Knight Cancer Institute | 2026-04-21 |
| A Study of Eltrekibart (LY3041658) in Healthy Participants (NCT07545590) | Eli Lilly and Company | 2026-04-21 |
| A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) (NCT07425522) | Genentech, Inc. | 2026-04-21 |
| A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants (NCT07635095) | Astria Therapeutics, Inc. | 2026-04-21 |
| A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD) (NCT07227207) | Tessera Therapeutics, Inc. | 2026-04-21 |
| Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) (NCT07531095) | Amgen | 2026-04-21 |
| A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation (NCT07458347) | Kestrel Therapeutics, Inc. | 2026-04-21 |
| A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants (NCT07600762) | AbbVie | 2026-04-21 |
| Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose. (NCT07545226) | Amgen | 2026-04-21 |
| GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas (NCT07417488) | Thomas Jefferson University | 2026-04-21 |
| Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial (NCT07161726) | University of Alabama at Birmingham | 2026-04-21 |
| Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza (NCT07215871) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-04-21 |
| Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia (NCT06802523) | National Cancer Institute (NCI) | 2026-04-21 |
| A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors (NCT07612176) | NEOK Bio, Inc. | 2026-04-21 |
| A Study of the Safety and Efficacy of the Intravenous and Intratumoral Injection of OVV-01 in Patients With Advanced Solid Tumours. (NCT07648472) | Joint Biosciences Ltd. | 2026-04-21 |
| Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer (NCT07231445) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2026-04-21 |
| Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation (NCT07566585) | BlueSphere Bio, Inc | 2026-04-21 |
| Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma (NCT07346144) | Trogenix ltd | 2026-04-21 |
| Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") (NCT07411599) | M.D. Anderson Cancer Center | 2026-04-20 |
| A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) (NCT07492303) | Changchun BCHT Biotechnology Co. | 2026-04-20 |
| A Crossover Study to Evaluate the Relative Bioavailability of Two Formulations of Deuterated Remdesivir Hydrobromide for Oral Suspension in Healthy Chinese Adults (NCT07510529) | Simcere Pharmaceutical Co., Ltd | 2026-04-20 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants (NCT07476586) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-04-20 |
| Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a) (NCT07551505) | Bisirna Therapeutics (Suzhou) Co., Ltd. | 2026-04-20 |
| A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects (NCT07560033) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2026-04-20 |
| Comparative Evaluation of Clinical and Radiographic Outcomes of Mustard Gel (Brassica Nigra) and Mineral Trioxide Aggregate (MTA) as Pulpotomy Agents in Deciduous Molars- A Randomized Controlled Trial (NCT07557290) | Dr Nida Farooq | 2026-04-20 |
| The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL (NCT07548255) | Ruijin Hospital | 2026-04-20 |
| Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS) (NCT07538479) | West China Hospital | 2026-04-20 |